SSAT058: Atripla to Eviplera Switch in Patients Without Central Nervous System Symptoms

NCT02529059 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: Eviplera

Sponsor

St Stephens Aids Trust

Collaborators

[object Object]